Immunome Inc.

NASDAQ: IMNM · Real-Time Price · USD
10.26
0.32 (3.22%)
At close: Aug 15, 2025, 3:46 PM

Immunome Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
143.35M 98.68M 20.32M 49.23M
Short-Term Investments
73.95M 39.46M n/a n/a
Long-Term Investments
100K 100K 100K 100K
Other Long-Term Assets
4.41M 100K 332K 332K
Receivables
n/a 289K 847K 4.31M
Inventory
n/a n/a n/a n/a
Other Current Assets
4.04M 4.99M n/a n/a
Total Current Assets
221.34M 144.7M 22.65M 56.64M
Property-Plant & Equipment
14.39M 3.64M 965K 855K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
18.9M 3.84M 1.4M 1.29M
Total Assets
240.24M 148.54M 24.05M 57.92M
Account Payables
14.19M 3.31M 2.4M 3.08M
Deferred Revenue
6.94M 10.49M n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
33.11M 4.98M 1.96M 2.02M
Total Current Liabilities
54.31M 21.83M 7.33M 9.73M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 5.49M n/a 12K
Total Long-Term Liabilities
4.77M 6.83M 62K 12K
Total Liabilities
59.08M 28.66M 7.39M 9.74M
Total Debt
4.83M 1.65M 291K 317K
Common Stock
6K 4K 1K 1K
Retained Earnings
-515.77M -222.81M -116M -79.11M
Comprehensive Income
57K 22K n/a -57.92M
Shareholders Equity
181.16M 119.88M 16.65M 48.19M
Total Investments
73.95M 39.56M 100K 100K